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Background: Eugenol is a potent phytochemical, and a plethora of delivery systems for this bioactive agent is
being developed. Reversed-phase high-pressure liquid chromatography equipped with photodiode array detector
(RP-HPLC-PDA) method is very useful in the quantification of the phytochemicals.
Methods: The RP-HPLC-PDA system with C18 reversed-phase column (250 × 4.6 mm, particle size 5 μm) was used
in this study. Acetonitrile and water in 1:1 (v/v) ratio was chosen as the mobile phase under a column temperature
of 25°C. The detection wavelength was set at 280 nm with a flow rate of 1 mL/min. Method validation was
performed according to the International Conference on Harmonization guidelines.
Results: HPLC method for the quantification of eugenol was successfully developed and validated. The method
was validated in terms of linearity and range, accuracy, precision, specificity, robustness, detection limit, and
quantitation limit.
Conclusions: The developed RP-HPLC-PDA could be successfully employed for the quantification of eugenol in
nanoemulsion gel and nanoparticles.
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A good number of novel delivery systems of eugenol
(Chen et al. 2009; Gomes et al. 2011; Jadhav et al. 2004;
Kriegel et al. 2010; Pokharkar et al. 2011) have been
reported owing to its potent bioacitivity. Anti-
inflammatory and anti-microbial actions are among
other major pharmacological actions of eugenol (Pramod
et al. 2010). Development of a suitable analytical method
will be needed when eugenol is formulated in
nanocarriers for targeted delivery.
Quantification of the pharmacologically active compo-
nent in a dosage form is indispensable to the quality
control of these systems. Quality control checks the
suitability of a drug delivery system for the intended
application. It serves as a marker for the consistency* Correspondence: javedaali@yahoo.com
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2013and predictability of the performance of dosage forms
(Levi et al. 1964). High-pressure liquid chromatography
(HPLC) methods are widely reported for the quantitative
estimation of bioactive phytochemicals, but to this
day, no reports are available on reversed-phase HPLC
equipped with photodiode array detector (RP-HPLC-
PDA) methods for the quantification of eugenol in nano-
structured delivery systems such as nanoemulsion gel
and nanoparticles. Besides this, none of the methods are
available for eugenol quantification from formulations
where a high specificity is required to overcome the
probable interference of the excipients.
Nanoemulsion gel and nanoparticles have been deve-
loped as novel drug delivery systems of eugenol (Pramod
et al. 2012, 2013). The major aim of the present work
was to develop a RP-HPLC-PDA method for the quanti-
tative estimation of eugenol in these drug delivery sys-
tems for anti-inflammation and periodontal infection.an open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Chromatographic conditions
Composition Value
Column C18 reverse phase column (250 × 4.6 mm,
particle size 5 μm; Merck, Darmstadt, Germany)
Flow rate 1 mL min-1
Retention time 7.968 ± 0.042 min
Detector PDA detector (Waters 2998)
Detection wavelength 280 nm
Injection volume 20 μL
Temperature 25°C
Elution type Isocratic
Run time 20 min
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Chemicals and reagents
Eugenol (pure) was purchased from Central Drug House
(Delhi, India). Poly-ε-caprolactone (MW 14,000), chitosan,
sodium alginate and Pluronic F-68 were purchased from
Sigma-Aldrich Co. (MO, USA). Tween 80 and polyvinyl
alcohol were purchased from Central Drug House (New
Delhi, India). Carbopol 940 was a gift sample from
Noveon Corporation (Cleveland, OH, USA). Tween 80
and triethanolamine were purchased from S D Fine-Chem
Ltd. (Mumbai, India). Ethanol (99.9%) was purchased
from Jiangsu Huax Co., Ltd. (Jiangsu, China). HPLC-grade
water and acetonitrile were purchased from Merck
(Mumbai, India).
Preparation of eugenol-loaded nanoemulsion gel and
nanoparticles
Aqueous titration method was employed for the pre-
paration of eugenol-loaded nanoemulsion. The formu-
lated eugenol-loaded nanoemulsion was converted to
nanoemulsion gel by dispersing 1% (w/w) Carbopol 940
in it. Tween 80 and ethanol were used as surfactant and
co-surfactant, respectively. For Smix, a specific volume
ratio of 4:1 (Tween 80/ethanol) was used (Pramod et al.
2012). For the preparation of the sample solution of
nanoemulsion gel, an accurately weighed gel sample was
taken in methanol, sonicated (Altrasonics, Mumbai,
India) for 20 min, and filtered using a 0.2-μm syringe fil-
ter (Axiva Sichem Biotech, New Delhi, India).
Solvent displacement method was employed for the
preparation of eugenol-loaded nanoparticles (Reis et al.
2006). Polycaprolactone (encapsulating polymer) and eu-
genol were dissolved in acetone (organic solvent phase)
by mild heating. The solution of eugenol and poly-
mer was injected dropwise into aqueous Pluronic F-68
(stabilizer) solution under magnetic stirring, and stirring
was continued until complete evaporation of acetone oc-
curred. Centrifugation of the suspension of nanoparticles
thus obtained was carried out at 15,000 rpm for 1 h.
The obtained nanoparticles were washed twice with dis-
tilled water and then freeze-dried (Pramod et al. 2013).
For the preparation of the sample solution from nano-
particles, accurately weighed sample of dried nanoparti-
cles was dissolved in 1 mL of acetone and then was
added to 5 mL of methanol. Acetone was then evapo-
rated. The sample was sonicated (Altrasonics, Mumbai,
India) for 20 min, then was made up to 10 mL with
methanol, and was filtered using a 0.2-μm syringe filter
(Axiva Sichem Biotech, New Delhi, India) (Pramod
et al. 2013).
HPLC instrumentation and chromatographic conditions
The HPLC method for the determination of eugenol was
carried out on a Waters Alliance e2695 separatingmodule (Waters Co., MA, USA) using a photodiode
array detector (Waters 2998) with autosampler and col-
umn oven. The instrument was controlled by Empower
2 software (Europa Science, Ltd., Cambridge, UK) in-
stalled with equipment for data collection and acquisition.
Compounds were separated on a C18 reversed-phase col-
umn (250 × 4.6 mm, particle size 5 μm; Merck, Darmstadt,
Germany) maintained at room temperature.
Mobile phase
Acetonitrile and water in the ratio of 1:1 (v/v) was
chosen as the mobile phase.
Chromatographic system
The chromatographic system is composed of the follow-
ing (Table 1): Chromatographic conditions.
Preparation of the mobile phase
HPLC-grade water was mixed with HPLC-grade aceto-
nitrile in the volume ratio of 1:1. The prepared mobile
phase was then filtered through a 0.45-μm nylon filter
and sonicated in an ultrasonic bath for 15 min.
Method validation
Linearity and range
A stock solution of eugenol (10 mg mL−1) was pre-
pared in methanol. Standard calibration solutions (5 to
1,000 μg mL−1) for the assessment of linearity were pre-
pared from this stock solution using the mobile phase.
The solutions were filtered through a 0.45-μm nylon fil-
ter. The filtered solution was then injected into the
HPLC system. The data of peak area versus drug con-
centration were treated by linear least square regression.
Accuracy as recovery
Accuracy was determined by recovery studies using stan-
dard addition method. The pre-analyzed samples were
spiked with extra 50%, 100%, and 150% of the standard
Figure 1 HPLC chromatogram of eugenol.
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method. The experiment was conducted in triplicate.
Precision
The intraday (repeatability) and interday (intermediate
precision) variations for the determination of eugenol
was carried out at three concentration levels of 20, 100,
and 600 μg mL−1. The determinations were carried out
in triplicate.
Specificity
The specificity of the method was ascertained by analy-
zing the standard drug and sample. The band for eu-
genol in nanoemulsion gel and nanoparticle samples was
confirmed by comparing the Rf values and spectra of the
band with that of the standard. The peak purity of eu-
genol was assessed by comparing the spectra at three
different levels, that is, peak start, peak apex, and peak
end positions of the spectrum.
Robustness
Robustness of the method was carried out by introdu-
cing very small changes in the analytical methodology atFigure 2 Calibration curve of eugenol by HPLC method.a single concentration level (100 μg mL−1). Robustness
of the proposed method was determined in two different
ways, i.e., by making deliberate changes in the mobile
phase ratio, flow rate, and detection wavelength of
analysis. The percentage of relative standard deviation
(%RSD) of the experiment was calculated to assess the
robustness of the method.
Detection and quantitation limits
The detection limit (DL) is the lowest amount of analyte
in a sample, which can be detected but not necessarily
quantitated. The quantitation limit (QL) is the lowest
amount of analyte in a sample, which can be quantita-
tively determined with suitable precision and accuracy.
The limit of quantification and limit of detection were
determined based on the technique of signal-to-noise ratio
(ICH Guidelines Q2(R1) 2005) using Equations 1 and 2:
QL ¼ 10σ=S ð1Þ
DL ¼ 3:3 σ=S ð2Þ
where σ is the standard deviation of the intercept of
the calibration plot and S is the slope of the calibration
curve.
Results and discussion
Although limited HPLC methods for the determination
of eugenol have been reported (Dighe et al. 2005; LiTable 2 Linear regression data for the calibration curve
(n = 3)
Parameter Mean ± SD %RSD
Linearity range (μg mL−1) 5 to 1,000 -
Correlation coefficient (R2) 0.9984 ± 0.0001 0.02
Slope 215,40.54 ± 63.93 0.30
Intercept 47,851.22 ± 2,880.31 6.02






of spiked sample (μg mL−1)
Concentration of spiked
sample ± SD (μg mL-1) (n = 3)
Recovery ± SD (%) %RSD
50 100 150 149.41 ± 1.87 99.60 ± 1.24 1.25
100 100 200 202.15 ± 1.36 101.07 ± 0.68 0.67
150 100 250 252.01 ± 1.82 100.80 ± 0.73 0.72
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quantifying eugenol in nanostructured delivery systems.
Moreover, the application of PDA detector is an added
advantage for the developed method. Detection of an
entire spectrum simultaneously is possible with PDA de-
tector. While UV–vis detectors visualize the obtained re-
sult in two dimensions (light intensity and time), only
PDA adds the third dimension (wavelength). This is
convenient to determine the most suitable wavelength
without repeating analyses. No methods are available for
eugenol quantification from formulations where a high
specificity is required to overcome the probable interfe-
rence of the excipients.
Calibration curve
A representative chromatogram of eugenol in the deve-
loped HPLC method is shown in Figure 1. A retention
time of 7.923 min can be observed from the HPLC chro-
matogram in Figure 1. The calibration curve for eugenol
by the developed HPLC method is shown in Figure 2.
The linear regression data for the calibration curve dem-
onstrated a good linear relationship over the concen-
tration range of 5 to 1,000 μg mL−1. A good linearity
was established by a correlation coefficient (R2) value of
0.9984 ± 0.0001 (Table 2). Correlation coefficient is a
statistical tool used to measure the degree or strength of
this type of relationship, and here, a high correlation co-
efficient value (a value very close to 1.0) indicates a high
level of linear relationship between the concentration of
eugenol and peak area. No significant differences were
observed in the slopes of standard curves as indicated by
the low %RSD of 0.30. Table 2 displays the linear regres-
sion data for the calibration curve of eugenol.
Accuracy as recovery
Accuracy was investigated by analyzing three concentra-
tions of the standard drug solution previously analyzedTable 4 Repeatability and intermediate precision of HPLC me
Concentration (μg mL−1) Repeatability (n = 3)
Mean peak area ± SD
20 468283.0 ± 3410.6
100 2213959.7 ± 11480.9
600 12800060.3 ± 45178.8using standard addition technique. The recovery studies
were carried out to check the sensitivity of the method
to estimate eugenol. The standard addition technique
was carried out by adding 50%, 100%, and 150% of eu-
genol concentration in the sample. The percentage re-
coveries of the three concentrations were found to be
99.60% to 101.07%, which is indicative of high accuracy.
The values of percentage recovery and %RSD are dis-
played in Table 3. The mean percentage recovery values,
close to 100%, and their low %RSD values indicated high
accuracy of the analytical method.
Precision
The repeatability of developed HPLC method, by intra-
day assay, is expressed in the terms of %RSD, and the re-
sults (Table 4) demonstrated the repeatability of the
method. The interday variation of eugenol at three dif-
ferent concentration levels of 20, 100, and 600 μg mL−1
establishes the intermediate precision of the method.
The low values of %RSD for repeatability and intermedi-
ate precision suggested an excellent precision of the de-
veloped HPLC method.
Specificity
The specificity of the developed method for the analysis
of eugenol in the nanoemulsion gel and nanoparticle
samples was confirmed by comparing the spectra ob-
tained in the standard and sample analyses (Figure 3).
The peak start, peak apex, and peak end positions of
these spectra were matching.
Robustness
Robustness was studied by introducing small changes in
the mobile phase ratio, flow rate, and detection wave-
length of analysis. The standard deviation and %RSD of
peak area and retention time (Rt) was calculated andthod
Intermediate precision (n = 3)
%RSD Mean peak area ± SD %RSD
0.73 467144.7 ± 3398.0 0.73
0.52 2213539.0 ± 8008.9 0.36
0.35 12778185.3 ± 40768.0 0.32
Figure 3 UV absorption spectra of eugenol in standard, nanoemulsion gel sample, and nanoparticle sample.
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bustness of the method.Detection and quantitation limits
The DL and QL were determined as per the ICH Guide-
lines Q2(R1) (2005) and were found to be 0.44 and
1.34 μg mL−1, respectively.Table 5 Robustness data of the HPLC method
Parameter Study condition Me
Original Used Level
Mobile phase ratio (ACN/water) 50:50 48:52 −1 2218
50:50 0
52:48 +1
Flow rate (mL min−1) 1.0 0.9 −1 2216
1.0 0
1.1 +1
Detection wavelength (nm) 280 278 −1 2214
280 0
282 +1
n = 3 at each level. Concentration = 100 μg mL−1.Conclusions
The RP-HPLC-PDA system with C18 reversed-phase
column (250 × 4.6 mm, particle size 5 μm) was used
in this study. Acetonitrile and water in the ratio of
1:1 (v/v) was chosen as the mobile phase, and a
detection wavelength of 280 nm was used with a
flow rate of 1 mL min−1. The method validation was
performed according to the guidelines of thean area ± SD %RSD of area Rt ± SD % RSD of Rt
634.9 ± 6686.7 0.30 7.968 ± 0.024 0.30
384.3 ± 8147.4 0.37 7.958 ± 0.068 0.85
941.3 ± 13356.9 0.60 7.967 ± 0.030 0.38
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HPLC method for the quantification of eugenol was
successfully developed and validated. The method
was validated in terms of linearity and range, accur-
acy, precision, specificity, robustness, detection limit,
and quantitation limit. The DL and QL were deter-
mined as per the ICH guidelines and were found to
be 0.44 and 1.34 μg mL−1, respectively. The devel-
oped RP-HPLC-PDA could be successfully employed
for the quantification of eugenol in its nanoemulsion
gel and nanoparticles.
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